Reduced risk of AIDS lymphoma in individuals heterozygous for the CCR5- Δ32 mutation

Cancer Research

Volumn 59, Issue 15, 1999, Pages 3561-3564

  Dean, Michael ^a   Jacobson, Lisa P ^c   McFarlane, Glen ^c   Margolick, Joseph B ^c   Jenkins, Frank J ^d   Howard, O M Zack ^e   Dong, Hui Fang ^a   Goedert, James J ^b   Buchbinder, Susan ^f   Gomperts, Edward ^g   Vlahov, David ^c   Oppenheim, Joost J ^a   O'Brien, Stephen J ^a   Carrington, Mary ^e  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d PRESBYTERIAN UNIVERSITY HOSPITAL   (United States)

^e SAIC FREDERICK INC   (United States)

^f S Francisco Dept of Public Health   (United States)

^g CHILDREN S HOSPITAL LOS ANGELES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CANCER RISK; CONTROLLED STUDY; GENE MUTATION; GENETIC SUSCEPTIBILITY; HUMAN; MAJOR CLINICAL STUDY; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; B-LYMPHOCYTES; CASE-CONTROL STUDIES; COHORT STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HIV-1; HUMANS; LYMPHOMA, AIDS-RELATED; MALE; POINT MUTATION; RANTES; RECEPTORS, CCR5; RISK; SARCOMA, KAPOSI; SEQUENCE DELETION; TETRADECANOYLPHORBOL ACETATE;

EID: 17444393539     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. D'Souza, M. P., and Harden, V. A. Chemokines and HIV-1 second receptors. Confluence of two fields generates optimism in AIDS research. Nat. Med., 2: 1293-1300, 1996.
2. Littman, D. R. Chemokine receptors: keys to AIDS pathogenesis? Cell, 93: 677-680, 1998.
3. Liu, R., Paxton, W. A., Choe, S., Ceradini, D., Martin, S. R., Horuk, R., MacDonald, M. E., Stuhlmann, H., Koup, R. A., and Landau, N. R. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell, 86: 367-377, 1996.
4. Samson, M., Libert, F., Doranz, B. J., Rucker, J., Liesnard, C., Farber, C. M., Saragosti, S., Lapoumeroulie, C., Cognaux, J., Forceille, C., Muyldermans, G., Verhofstede, C., Burtonboy, G., Georges, M., Imai, T., Rana, S., Yi, Y., Smyth, R. J., Collman, R. G., Doms, R. W., Vassart, G., and Parmentier, M. Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature (Lond.), 382: 722-725, 1996.
5. Dean, M., Carrington, M., Winkler, C., Huttley, G. A., Smith, M. W., Allikmets, R., Goedert, J. J., Buchbinder, S. P., Vittinghoff, E., Gomperts, E., Donfield, S., Vlahov, D., Kaslow, R., Saah, A., Rinaldo, C., Detels, R., and O'Brien, S. J. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study. Science (Washington DC), 273: 1856-1862, 1996.
6. Zimmerman, P. A., Buckler-White, A., Alkhatib, G., Spalding, T., Kubofcik, J., Combadiere, C., Weissman, D., Cohen, O., Rubbert, A., Lam, G., Vaccarezza, M., Kennedy, P. E., Kumaraswami, V., Giorgi, J. V., Detels, R., Hunter, J., Chopek, M., Berger, E. A., Fauci, A. S., Nutman, T. B., and Murphy, P. M. Inherited resistance to HIV-1 conferred by an inactivating mutation in CC chemokine receptor 5: studies in populations with contrasting clinical phenotypes, defined racial background, and quantified risk. Mol. Med., 3: 23-36, 1997.
7. Huang, Y., Paxton, W. A., Wolinsky, S. M., Neumann, A. U., Zhang, L., He, T., Kang, S., Ceradini, D., Jin, Z., Yazdanbakhsh, K., Kunstman, K., Erickson, D., Dragon, E., Landau, N. R., Phair, J., Ho, D. D., and Koup, R. A. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nat. Med., 2: 1240-1243, 1996.
8. Michael, N. L., Louie, L. G., Rohrhaugh, A. L., Schultz, K. A., Dayhoff, D. E., Wang, C. E., and Sheppard, H. W. The role of CCR5 and CCR2 polymorphisms in HIV-1 transmission and disease progression. Nat. Med., 3: 1160-1162, 1997.
9. de Roda Husman, A. M., Koot, M., Cornelissen, M., Keet, I. P., Brouwer, M., Broersen, S. M., Bakker, M., Roos, M. T., Prins, M., de Wolf, F., Coutinho, R. A., Miedema, F., Goudsmit, J., and Schuitemaker, H. Association between CCR5 genotype and the clinical course of HIV-1 infection. Ann. Intern. Med., 127: 882-890, 1997.
10. Gaidano, G., Carbone, A., and Dalla-Favera, R. Pathogenesis of AIDS-related lymphomas. Am. J. Pathol., 152: 623-630, 1998.
11. Straus, D. J. HIV-associated lymphomas. Curr. Opin. Oncol., 9: 450-454, 1997.
12. Armenian, H. K., Hoover, D. R., Rubb, S., Metz, S., Martinez-Maza, O., Chmiel, J., Kingsley, L., and Saah, A. Risk factors for non-Hodgkin's lymphomas in acquired immunodeficiency syndrome (AIDS). Am. J. Epidemiol., 143: 374-379, 1996.
13. Kaslow, R. A., Ostrow, D. G., Detels, R., Phair, J. P., Polk, B. F., and Rinaldo, C. R. J. The Multicenter AIDS Cohort Study: rationale, organization, and selected characteristics of the participants. Am. J. Epidemiol., 126: 310-318, 1987.
14. U.S. Centers for Disease Control. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Morb. Mortal. Wkly. Rep., 41: 1-19, 1992.
15. Giorgi, J. V., Cheng, H. L., Margolick, J. B., Bauer, K. D., Ferbas, J., Waxdal, M., Schmid, I., Hultin, L. E., Jackson, A. L., Park, L., et al. Quality control in the flow cytometric measurement of T-lymphocyte subsets: the Multicenter AIDS Cohort Study experience. The Multicenter AIDS Cohort Study Group. Clin. Immunol. Immunopathol., 55: 173-186, 1990.
16. Schenker, E. L., Hultin, L. E., Bauer, K. D., Ferbas, J., Margolick, J. B., and Giorgi, J. V. Evaluation of a dual-color flow cytometry immunophenotyping panel in a multicenter quality assurance program. Cytometry, 14: 307-317, 1993.
17. Mellors, J. W., Munoz, A., Giorgi, J. V., Margolick, J. B., Tassoni, C. J., Gupta, P., Kingsley, L. A., Todd, J. A., Saah, A. J., Detels, R., Phair, J. P., and Rinaldo, C. R., Jr. Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Ann. Intern. Med., 126: 946-954, 1997.
18. Munoz, A., Carey, V., Taylor, J. M., Chmiel, J. S., Kingsley, L., Van Raden, M., and Hoover, D. R. Estimation of time since exposure for a prevalent cohort. Stat. Med., 11: 939-952, 1992.
19. Detels, R. Recent scientific contributions to understanding HIV/AIDS from the Multicenter AIDS Cohort Study. J. Epidemiol., 2: S11-S19, 1992.
20. Smith, M. W., Dean, M., Carrington, M., Winkler, C., Huttley, G. A., Lomb, D. A., Goedert, J. J., O'Brien, T. R., Jacobson, L. P., Kaslow, R., Buchbinder, S., Vittinghoff, E., Vlahov, D., Hoots, K., Hilgartner, M. W., and O'Brien, S. J. Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study. Science (Washington DC), 277: 959-965, 1997.
21. Kostrikis, L. G., Huang, Y., Moore, J. P., Wolinsky, S. M., Zhang, L., Guo, Y., Deutsch, L., Phair, J., Neumann, A. U., and Ho, D. D. A chemokine receptor CCR2 allele delays HIV-1 disease progression and is associated with a CCR5 promoter mutation. Nat. Med., 4: 350-353, 1998.
22. Martin, M. P., Dean, M., Smith, M. W., Winkler, C., Gerrard, B., Michael, N. L., Lee, B., Doms, R. W., Margolick, J., Buchbinder, S., Goedert, J. J., O'Brien, T. R., Hilgartner, M. W., Vlahov, D., O'Brien, S. J., and Carrington, M. Genetic acceleration of AIDS progression by a promoter variant of CCR5. Science (Washington DC), 282: 1907-1911, 1998.
23. Bacon, K. B., Premack, B. A., Gradner, P., and Schall, T. J. Activation of dual T cell signaling pathways by the chemokine RANTES. Science (Washington DC), 269: 1727-1730, 1995.
24. Benkirane, M., Jin, D. Y., Chun, R. F., Koup, R. A., and Jeang, K. T. Mechanism of transdominant inhibition of CCR5-mediated HIV-1 infection by ccr5Δ32. J. Biol. Chem., 272: 30603-30606, 1997.
25. Armenian, H. K., and Hamadeh, R. R. Epidemiology of non-Hodgkin's lymphoma. Rev. Cancer Epidemiol., 2: 141-169, 1983.
26. Raport, C. J., Gosling, J., Schweickart, V. L., Gray, P. W., and Charo, I. F. Molecular cloning and functional characterization of a novel human CC chemokine receptor (CCR5) for RANTES, MIP-1α, and MIP-1β. J. Biol. Chem., 271: 17161-17166, 1996.
27. Rollins, B. J. Chemokines. Blood, 90: 909-928, 1997.
28. Muller, P., Engelstadter, M., Werner, A., Braner, J., Staszewski, S., Miller, V., Doerr, H. W., Kurth, R., and Cichutek, K. Increased serum and mRNA levels of RANTES associated with elevated levels of activated CD8+CD38+ T cells in HIV-1 infected individuals, Intervirology, 40: 263-270, 1997.
29. Cairns, J. S., and D'Souza, M. P. Chemokines and HIV-1 second receptors: the therapeutic connection. Nat. Med., 4: 563-568, 1998.